Eventide Asset Management’s Evommune EVMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,209,129
Closed -$16.1M – 364
2026
Q2
$16.1M Hold
1,209,129
– – 0.21% 125
2026
Q1
$27.8M Buy
1,209,129
+247,604
+26% +$5.6M 0.46% 75
2025
Q4
$16.5M Buy
+961,525
New +$18.1M 0.26% 112

Other funds holding EVMN

Eventide Asset Management's EVMN Position: Q3 2026 in Review

Eventide Asset Management sold out of Evommune (EVMN) in Q3 2026, closing a stake of 1,209,129 shares — an estimated $16.1M sold.

Eventide Asset Management first reported a position in EVMN in Q4 2025 and held it in 3 quarters. The position peaked at $27.8M in Q1 2026. 99 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • Eventide Asset Management reported no remaining Evommune position as of Q3 2026 after selling out during the quarter.
  • Eventide Asset Management sold 1,209,129 Evommune shares in Q3 2026, an estimated $16.1M.
  • Eventide Asset Management first reported a position in Evommune in Q4 2025 and held it in 3 quarters.
  • Eventide Asset Management's Evommune position peaked at $27.8M in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Evommune as of Q3 2026.

Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.